BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20675862)

  • 1. Giant Cell Tumor (tumor gigantocellularis, osteoclastoma) - epidemiology, diagnosis, treatment.
    Karpik M
    Ortop Traumatol Rehabil; 2010; 12(3):207-15. PubMed ID: 20675862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell tumour of first metacarpal bone.
    Shahid M; Varshney M; Maheshwari V; Mubeen A; Gaur K; Siddiqui M
    BMJ Case Rep; 2011 Mar; 2011():. PubMed ID: 22701064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant giant cell tumour of distal ulna.
    Yadav SK; Rajnish RK; Prakash V; Nalwa A
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38350706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Humeral localization of a recurrent giant cell tumor (about one case)].
    Nader Y; Serghini I; Koulali IK; Salahi H; Galwia F
    Pan Afr Med J; 2015; 20():12. PubMed ID: 25995809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic Acid Supplementation With Excision of a Giant Cell Tumor of the Distal End Radius to Prevent Recurrence: A Case Report.
    Lohiya A; Dhaniwala N; Jadhav S; Patel SK; Goyal S
    Cureus; 2024 Mar; 16(3):e55794. PubMed ID: 38586778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.
    Adachi Y; Noguchi R; Yoshimatsu Y; Sin Y; Osaki J; Ono T; Iwata S; Akiyama T; Tsuchiya R; Toda Y; Ishihara S; Ogura K; Kobayashi E; Kojima N; Yoshida A; Yokoo H; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):874-885. PubMed ID: 38466561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Retrospective Observational Study on Disease Characteristics and Treatment Patterns of Giant Cell Tumor of the Bone in China.
    Xu H; Li Y; Wang T; Liu W; Ma K; Yang Y; Huang Z; Li C; Niu X
    J Cancer Epidemiol; 2023; 2023():5468291. PubMed ID: 37153026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Triple clear': a systematic and comprehensive surgical process for Campanacci grades II and III giant cell tumors of the bone, with or without pathological fracture and slight joint invasion.
    Wang Y; Shao P; Tian Q; Li H; Li J; Ren P; Lv Z; Lv J; Bai J; Feng Y
    World J Surg Oncol; 2023 Mar; 21(1):114. PubMed ID: 36978172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant-cell-poor giant cell tumor of bone: report of two cases and literature review.
    Yakoub MA; Torrence D; Hwang S; Bartelstein M; Healey JH; Hameed M
    Skeletal Radiol; 2023 Sep; 52(9):1791-1798. PubMed ID: 36781420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Audit of Demography and Different Surgical Modalities Adopted for Giant Cell Tumor of Bone in Eastern India.
    Kumar I; Ahmed W; Kashyap N; Kumar M; Saw MK; Shekhar R
    Cureus; 2022 Sep; 14(9):e29520. PubMed ID: 36312651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Giant Cell Tumor of Distal Radius with Pulmonary Metastasis: A Case Report.
    Pai SN; Rajappa S
    J Orthop Case Rep; 2021 Dec; 11(12):73-76. PubMed ID: 35415135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognosis of giant cell tumor of bone and the vital risk factors that affect its postoperative recurrence: a meta-analysis.
    Lin X; Liu J; Xu M
    Transl Cancer Res; 2021 Apr; 10(4):1712-1722. PubMed ID: 35116496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Recurrence After Minimally Invasive Curettage For Primary Giant Cell Tumor of Bone With Perioperative Bisphosphonate Is Comparable to Open Curettage: Retrospective Comparison With 9-Year Follow-Up.
    Lau HW; Wong KC; Chiu WK; Kumta SM
    Arthrosc Sports Med Rehabil; 2021 Dec; 3(6):e1729-e1736. PubMed ID: 34977627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the Cavity After Removal of Giant Cell Tumor of the Bone.
    Wang Y; Tian Q; Wu C; Li H; Li J; Feng Y
    Front Surg; 2021; 8():626272. PubMed ID: 34395504
    [No Abstract]   [Full Text] [Related]  

  • 15. Establishment and characterization of novel patient-derived cell lines from giant cell tumor of bone.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Sin Y; Akane S; Sugaya J; Mori T; Fukushima S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2021 Nov; 34(6):1899-1910. PubMed ID: 34304386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bisphosphonates on local recurrence of giant cell tumor of bone: a meta-analysis.
    Shi M; Chen L; Wang Y; Wang W; Zhang Y; Yan S
    Cancer Manag Res; 2019; 11():669-680. PubMed ID: 30666162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent giant cell tumour of the maxillary sinus and pterygoid process treated with denosumab.
    Rosa D; Dias RB; Salvador JC; Borges A
    BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30196254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of decreased programmed cell death 4 expression in patients with giant cell tumors of the bone.
    Gao F; Zhang W; Ding L; Zhao M; Ma Z; Huang S
    Oncol Lett; 2018 Sep; 16(3):3805-3811. PubMed ID: 30127992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to Fill the Cavity after Curettage of Giant Cell Tumors around the Knee? A Multicenter Analysis.
    Zheng K; Yu XC; Hu YC; Wang Z; Wu SJ; Ye ZM;
    Chin Med J (Engl); 2017 Nov; 130(21):2541-2546. PubMed ID: 29067952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoprosthetic Reconstruction of distal Humerus following Resection of distal Humeral Giant Cell Tumours in Six Patients in Rural India.
    Balasubramanian N; Gnanasundaram R; Prakasam S
    Malays Orthop J; 2017 Jul; 11(2):25-29. PubMed ID: 29021875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.